Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

654
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
654
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

243
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
243
Sedatives and Hypnotics Drugs: Barbiturates01:20

Sedatives and Hypnotics Drugs: Barbiturates

480
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
480
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

388
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
388
Stages of General Anesthesia01:22

Stages of General Anesthesia

714
Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
714
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

472
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
472

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Double effect sedation: reply to commentaries.

Journal of medical ethics·2025
Same author

Intending to avoid the treatment burdens only: the doctrine of double effect and withholding or withdrawing life-sustaining treatment.

Theoretical medicine and bioethics·2025
Same author

Continuous deep sedation and the doctrine of double effect: Do physicians not intend to make the patient unconscious until death if they gradually increase the sedatives?

Bioethics·2020
Same author

An International Legal Review of the Relationship between Brain Death and Organ Transplantation.

The Journal of clinical ethics·2018
Same author

Integration of palliative and supportive cancer care in Asia.

The Lancet. Oncology·2012

相关实验视频

Updated: Sep 13, 2025

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

20.0K

双效镇静:当药物也可以减少特定症状时,医生是否不打算减少意识?

Hitoshi Arima1

  • 1Graduate School of Urban Social and Cultural Studies, Yokohama City University, Yokohama, Kanagawa, Japan harima@buffalo.edu arima@yokohama-cu.ac.jp.

Journal of medical ethics
|July 25, 2025
PubMed
概括

息镇静的伦理是复杂的. 双效镇静 (DES) 使用药物来缓解症状和镇静,但医生通常打算减少意识,挑战道德理由.

科学领域:

  • 医学伦理 医学伦理
  • 抚慰性护理是一种缓解性护理.
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 缓解性镇静在伦理上受到争议,特别是当镇静药物也可以缓解症状时.
  • 像米达佐拉姆和吗啡这样的药物可以减少症状 (发作,疼痛,呼吸困难),同时也降低意识.
  • 这种双重作用被称为双重效应镇静 (DES).

研究的目的:

  • 检查围绕双效镇静剂 (DES) 的伦理要求.
  • 调查 DES 中意识的减弱是否总是意想不到的副作用.
  • 确定双重效应学说 (DDE) 是否可以在道德上证明 DES 的合理性.

主要方法:

  • 对息镇静和双重效应学说的伦理论据的分析.
  • 检查临床场景,其中镇静药物用于症状管理.
  • 哲学调查医生在DES中的行为意向性.

主要成果:

  • 声称在DES中减少意识只是副作用的说法往往是错误的.
  • 医生经常打算在给予DES时减少意识.
  • 预期或长期减少意识并不能自动使其成为副作用.
关键词:
疼痛管理 疼痛管理抚慰性护理是一种缓解性护理.终端护理 终端护理

更多相关视频

Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
14:52

Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers

Published on: January 13, 2018

11.1K
Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
08:49

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention

Published on: October 16, 2013

13.8K

相关实验视频

Last Updated: Sep 13, 2025

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

20.0K
Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
14:52

Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers

Published on: January 13, 2018

11.1K
Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
08:49

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention

Published on: October 16, 2013

13.8K

结论:

  • 双重效应学说 (DDE) 可能不能证明DES的正当性,当意识的减少是有意的.
  • DES,特别是当意识是一个预期的效果时,需要严格的道德评估.
  • 这些病例应与没有缓解症状的镇静药物进行类似的评估.